Association of lipoprotein (a) and 1 year prognosis in patients with heart failure with reduced ejection fraction
Lp(a) and CHF prognosis
Related Articles
Telcos are cutting jobs but not because of AI
The jobs tsunami hasn’t yet appeared but AI has already become a handy scapegoat for layoffs.
Real-World Analysis Suggests Social Determinants of Health May Be Associated With Early Onset of CRC
Jessica Paulus, ScD, highlights factors that may contribute to the increasing incidence of colorectal cancer in patients younger than 50 years of age.
Incidence and Nature of Antidepressant Discontinuation Symptoms
This systematic review and meta-analysis examines the presence and incidence of discontinuation symptoms in individuals who stop taking antidepressants.
Education and Accelerated Tau Accumulation in Alzheimer Disease
This cohort study investigates if higher educational attainment is associated with rate of tau accumulation.
Acne Keloidalis Nuchae
This Patient Page describes the symptoms, diagnosis, and treatment of acne keloidalis nuchae.
Proximity to Golf Courses and Risk of Parkinson Disease
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Endothelial Dysfunction and Chronic Cannabis Use
This cross-sectional study aims to determine whether cannabis use is associated with vascular endothelial function.
Trends in US Children’s Mortality, Chronic Conditions, Obesity, Functional Status, and Symptoms
This study aims to determine how US children’s health has been changing from 2007 to 2023 using multiple data collection methods and a comprehensive set…
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
This cohort study conducted in Ontario, Canada, evaluates the risk of developing neovascular age-related macular degeneration associated with the use of glucagon-like peptide-1 receptor agonists…
Private Equity Acquisition of Gastroenterology Practices and Colonoscopy Price and Quality
This economic evaluation assesses how private equity ownership of gastroenterology practices affects colonoscopy prices, spending, utilization, and quality.
